Publication at First Faculty of Medicine |
2011
Abstract
New drugs based on inhibition of dipeptidyl-peptidase 4 have side effects originating from their influence on immune system and targeting some pathways in cancer development.
New drugs based on inhibition of dipeptidyl-peptidase 4 have side effects originating from their influence on immune system and targeting some pathways in cancer development.